Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
US5733919 | MEDICURE | Compositions for inhibiting platelet aggregation |
Oct, 2016
(7 years ago) | |
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US5965581 | MEDICURE | Compositions for inhibiting platelet aggregation |
Oct, 2016
(7 years ago) | |
US5972967 | MEDICURE | Compositions for inhibiting platelet aggregation |
Oct, 2016
(7 years ago) | |
US5733919 | MEDICURE | Compositions for inhibiting platelet aggregation |
Oct, 2016
(7 years ago) | |
US5978698 | MEDICURE | Angioplasty procedure using nonionic contrast media |
Oct, 2017
(6 years ago) | |
US6136794 | MEDICURE | Platelet aggregation inhibition using low molecular weight heparin in combination with a GP IIb/IIIa antagonist |
Jan, 2019
(5 years ago) | |
US6770660 | MEDICURE | Method for inhibiting platelet aggregation |
May, 2023
(1 year, 2 days ago) |
Aggrastat is owned by Medicure.
Aggrastat contains Tirofiban Hydrochloride.
Aggrastat has a total of 7 drug patents out of which 7 drug patents have expired.
Expired drug patents of Aggrastat are:
Aggrastat was authorised for market use on 14 May, 1998.
Aggrastat is available in solution;intravenous, injectable;injection, solution;injection dosage forms.
Aggrastat can be used as a dosing regimen of aggrastat (tirofiban hydrochloride)(25mcg/kg followed by 0.15mcg/kg/min infusion) to reduce the rate of thrombotic coronary events associated with acute coronary syndrome (acs) in patients with non-st elevation acs, method of treating acs using angioplasty with aggrastat (tirofiban hydrochloride).
The generics of Aggrastat are possible to be released after 01 May, 2023.
Drugs and Companies using TIROFIBAN HYDROCHLORIDE ingredient
Market Authorisation Date: 14 May, 1998
Treatment: Method of treating acs using angioplasty with aggrastat (tirofiban hydrochloride); A dosing regimen of aggrastat (tirofiban hydrochloride)(25mcg/kg followed by 0.15mcg/kg/min infusion) to reduce the r...
Dosage: INJECTABLE;INJECTION; SOLUTION;INTRAVENOUS; SOLUTION;INJECTION